JP2009539378A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009539378A5 JP2009539378A5 JP2009514393A JP2009514393A JP2009539378A5 JP 2009539378 A5 JP2009539378 A5 JP 2009539378A5 JP 2009514393 A JP2009514393 A JP 2009514393A JP 2009514393 A JP2009514393 A JP 2009514393A JP 2009539378 A5 JP2009539378 A5 JP 2009539378A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell
- stem cells
- collagen biofabric
- stem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 53
- 102000008186 Collagen Human genes 0.000 claims 30
- 108010035532 Collagen Proteins 0.000 claims 30
- 229920001436 collagen Polymers 0.000 claims 30
- 210000004027 cell Anatomy 0.000 claims 29
- 210000000130 stem cell Anatomy 0.000 claims 27
- 230000014509 gene expression Effects 0.000 claims 10
- 238000004519 manufacturing process Methods 0.000 claims 10
- 238000012258 culturing Methods 0.000 claims 9
- 230000004069 differentiation Effects 0.000 claims 9
- 108090000623 proteins and genes Proteins 0.000 claims 9
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 8
- 102000004877 Insulin Human genes 0.000 claims 4
- 108090001061 Insulin Proteins 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims 4
- 229960003957 dexamethasone Drugs 0.000 claims 4
- 210000003494 hepatocyte Anatomy 0.000 claims 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims 4
- 229940125396 insulin Drugs 0.000 claims 4
- 210000001988 somatic stem cell Anatomy 0.000 claims 4
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims 3
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims 3
- 210000002449 bone cell Anatomy 0.000 claims 3
- 230000000747 cardiac effect Effects 0.000 claims 3
- 210000001612 chondrocyte Anatomy 0.000 claims 3
- 210000004993 mammalian placenta Anatomy 0.000 claims 3
- 210000002569 neuron Anatomy 0.000 claims 3
- 210000002826 placenta Anatomy 0.000 claims 3
- 210000004991 placental stem cell Anatomy 0.000 claims 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 2
- APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 claims 2
- 102000007469 Actins Human genes 0.000 claims 2
- 108010085238 Actins Proteins 0.000 claims 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims 2
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims 2
- 101800003838 Epidermal growth factor Proteins 0.000 claims 2
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 claims 2
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 claims 2
- 101001111338 Homo sapiens Neurofilament heavy polypeptide Proteins 0.000 claims 2
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 claims 2
- 102000004882 Lipase Human genes 0.000 claims 2
- 108090001060 Lipase Proteins 0.000 claims 2
- 239000004367 Lipase Substances 0.000 claims 2
- 102100024007 Neurofilament heavy polypeptide Human genes 0.000 claims 2
- 102000004264 Osteopontin Human genes 0.000 claims 2
- 108010081689 Osteopontin Proteins 0.000 claims 2
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 claims 2
- 108010009583 Transforming Growth Factors Proteins 0.000 claims 2
- 102000009618 Transforming Growth Factors Human genes 0.000 claims 2
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 claims 2
- 102000056172 Transforming growth factor beta-3 Human genes 0.000 claims 2
- 108090000097 Transforming growth factor beta-3 Proteins 0.000 claims 2
- 210000001789 adipocyte Anatomy 0.000 claims 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims 2
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims 2
- 210000001691 amnion Anatomy 0.000 claims 2
- 230000006907 apoptotic process Effects 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 210000001185 bone marrow Anatomy 0.000 claims 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims 2
- 230000030833 cell death Effects 0.000 claims 2
- 210000001136 chorion Anatomy 0.000 claims 2
- 230000003511 endothelial effect Effects 0.000 claims 2
- 229940116977 epidermal growth factor Drugs 0.000 claims 2
- 210000004700 fetal blood Anatomy 0.000 claims 2
- 210000002064 heart cell Anatomy 0.000 claims 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 2
- 229920002674 hyaluronan Polymers 0.000 claims 2
- 229960003160 hyaluronic acid Drugs 0.000 claims 2
- 229960000905 indomethacin Drugs 0.000 claims 2
- 235000019421 lipase Nutrition 0.000 claims 2
- 210000004185 liver Anatomy 0.000 claims 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims 2
- 210000001665 muscle stem cell Anatomy 0.000 claims 2
- 230000017074 necrotic cell death Effects 0.000 claims 2
- 210000001178 neural stem cell Anatomy 0.000 claims 2
- 230000003169 placental effect Effects 0.000 claims 2
- 229930002330 retinoic acid Natural products 0.000 claims 2
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 claims 2
- 210000001082 somatic cell Anatomy 0.000 claims 2
- 230000004083 survival effect Effects 0.000 claims 2
- 229940099456 transforming growth factor beta 1 Drugs 0.000 claims 2
- 229960001727 tretinoin Drugs 0.000 claims 2
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims 1
- 108010025020 Nerve Growth Factor Proteins 0.000 claims 1
- 102000015336 Nerve Growth Factor Human genes 0.000 claims 1
- 102000007339 Nerve Growth Factor Receptors Human genes 0.000 claims 1
- 108010032605 Nerve Growth Factor Receptors Proteins 0.000 claims 1
- 102000008730 Nestin Human genes 0.000 claims 1
- 108010088225 Nestin Proteins 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 239000003636 conditioned culture medium Substances 0.000 claims 1
- 230000003583 cytomorphological effect Effects 0.000 claims 1
- 229940126864 fibroblast growth factor Drugs 0.000 claims 1
- 230000002503 metabolic effect Effects 0.000 claims 1
- 229940053128 nerve growth factor Drugs 0.000 claims 1
- 210000005055 nestin Anatomy 0.000 claims 1
- 210000003061 neural cell Anatomy 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 230000010349 pulsation Effects 0.000 claims 1
- 238000010186 staining Methods 0.000 claims 1
- 231100000331 toxic Toxicity 0.000 claims 1
- 230000002588 toxic effect Effects 0.000 claims 1
- 231100000419 toxicity Toxicity 0.000 claims 1
- 230000001988 toxicity Effects 0.000 claims 1
- 230000014616 translation Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81236606P | 2006-06-09 | 2006-06-09 | |
| PCT/US2007/013507 WO2007146123A2 (en) | 2006-06-09 | 2007-06-08 | Placental niche and use thereof to culture stem cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009539378A JP2009539378A (ja) | 2009-11-19 |
| JP2009539378A5 true JP2009539378A5 (cg-RX-API-DMAC7.html) | 2010-07-29 |
Family
ID=38832407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009514393A Pending JP2009539378A (ja) | 2006-06-09 | 2007-06-08 | 胎盤環境及び幹細胞を培養するためのその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20080044848A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2035552A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009539378A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20090031895A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101501185A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007258514A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2654716A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL195826A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2008015645A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007146123A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200810412B (cg-RX-API-DMAC7.html) |
Families Citing this family (86)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03005014A (es) * | 2000-12-06 | 2004-09-10 | Robert J Hariri | Metodo para recolectar celulas madres de la placenta. |
| US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
| US20080152629A1 (en) * | 2000-12-06 | 2008-06-26 | James Edinger | Placental stem cell populations |
| EP2338983B1 (en) | 2001-02-14 | 2015-10-07 | Anthrogenesis Corporation | Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells |
| US7498171B2 (en) * | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| AU2003298775B2 (en) * | 2002-11-26 | 2008-07-17 | Anthrogenesis Corporation | Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
| GB0321337D0 (en) * | 2003-09-11 | 2003-10-15 | Massone Mobile Advertising Sys | Method and system for distributing advertisements |
| BRPI0417186A (pt) * | 2003-12-02 | 2007-03-06 | Celgene Corp | método de tratamento de um indivìduo tendo uma hemoglobinopatia ou uma anemia, de modulação da diferenciação de uma célula-tronco ou precursora de cd34+ para uma linhagem de eritróides, e, composição farmacêutica |
| JP2007531116A (ja) * | 2004-03-26 | 2007-11-01 | セルジーン・コーポレーション | 幹細胞バンクを提供するためのシステム及び方法 |
| AU2006304274B2 (en) * | 2005-10-13 | 2012-08-16 | Celularity Inc. | Production of oligodendrocytes from placenta-derived stem cells |
| EP1957633B1 (en) | 2005-10-13 | 2013-12-18 | Anthrogenesis Corporation | Immunomodulation using placental stem cells |
| KR20180105266A (ko) | 2005-12-29 | 2018-09-27 | 안트로제네시스 코포레이션 | 태반 줄기 세포 집단 |
| AU2006332679A1 (en) * | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
| US9598669B2 (en) | 2005-12-29 | 2017-03-21 | Anthrogenesis Corporation | Composition for collecting placental stem cells and methods of using the composition |
| US7993918B2 (en) | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
| WO2008021391A1 (en) * | 2006-08-15 | 2008-02-21 | Anthrogenesis Corporation | Umbilical cord biomaterial for medical use |
| US8372437B2 (en) | 2006-08-17 | 2013-02-12 | Mimedx Group, Inc. | Placental tissue grafts |
| US20080131522A1 (en) * | 2006-10-03 | 2008-06-05 | Qing Liu | Use of placental biomaterial for ocular surgery |
| US8071135B2 (en) | 2006-10-04 | 2011-12-06 | Anthrogenesis Corporation | Placental tissue compositions |
| AU2007318210B2 (en) | 2006-10-06 | 2014-02-20 | Celularity Inc. | Native (telopeptide) placental collagen compositions |
| NZ606814A (en) | 2006-10-23 | 2014-10-31 | Anthrogenesis Corp | Methods and compositions for treatment of bone defects with placental cell populations |
| JP2010518812A (ja) * | 2007-02-12 | 2010-06-03 | アンスロジェネシス コーポレーション | 接着性胎盤幹細胞由来の肝細胞および軟骨細胞、ならびにcd34+、cd45−胎盤幹細胞の濃縮細胞集団 |
| CN103356710A (zh) * | 2007-02-12 | 2013-10-23 | 人类起源公司 | 利用胎盘干细胞治疗炎性疾病 |
| US20100172830A1 (en) * | 2007-03-29 | 2010-07-08 | Cellx Inc. | Extraembryonic Tissue cells and method of use thereof |
| US9200253B1 (en) | 2007-08-06 | 2015-12-01 | Anthrogenesis Corporation | Method of producing erythrocytes |
| EP2197270B8 (en) | 2007-09-07 | 2020-03-04 | Surgical Biologics, LLC | Placental tissue grafts and improved methods of preparing and using the same |
| KR20200136051A (ko) * | 2007-09-26 | 2020-12-04 | 안트로제네시스 코포레이션 | 인간 태반 관류액으로부터의 혈관형성 세포 |
| EP2203176B1 (en) | 2007-09-28 | 2014-11-26 | Anthrogenesis Corporation | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
| AU2008325142A1 (en) * | 2007-11-07 | 2009-05-14 | Anthrogenesis Corporation | Use of umbilical cord blood in the treatment of premature birth complications |
| US9358320B2 (en) | 2008-04-25 | 2016-06-07 | Allosource | Multi-layer tissue patches |
| US9480549B2 (en) | 2008-04-25 | 2016-11-01 | Allosource | Multi-layer tissue patches |
| US20110129520A1 (en) * | 2008-04-25 | 2011-06-02 | Simon Bogdansky | Anti-Adhesion Barrier Wound Dressing Comprising Processed Amniotic Tissue and Method of Use |
| ITRM20080342A1 (it) * | 2008-06-26 | 2009-12-27 | Univ Degli Studi Udine | Cellule di polpa dentale midollo-simili, metodi per isolamento ed uso. |
| NZ591292A (en) * | 2008-08-20 | 2012-10-26 | Anthrogenesis Corp | Improved cell composition and methods of making the same |
| CA2734237C (en) * | 2008-08-20 | 2019-07-02 | Anthrogenesis Corporation | Treatment of stroke using isolated placental cells |
| SI2331109T1 (sl) * | 2008-08-22 | 2013-10-30 | Anthrogenesis Corporation | Postopki in sestavki za zdravljenje okvar kosti s populacijami placentarnih celic |
| KR101019877B1 (ko) | 2008-10-07 | 2011-03-04 | 사회복지법인 삼성생명공익재단 | 지방세포 분화용 배지 조성물 |
| WO2010059828A1 (en) | 2008-11-19 | 2010-05-27 | Anthrogenesis Corporation | Amnion derived adherent cells |
| EP2375907B1 (en) * | 2008-11-21 | 2019-02-27 | Celularity, Inc. | Treatment of diseases, disorders or conditions of the lung using placental cells |
| EP2449095A1 (en) * | 2009-07-02 | 2012-05-09 | Anthrogenesis Corporation | Method of producing erythrocytes without feeder cells |
| CA2787992A1 (en) * | 2010-01-26 | 2011-08-04 | Anthrogenesis Corporation | Treatment of bone-related cancers using placental stem cells |
| WO2011103462A1 (en) | 2010-02-18 | 2011-08-25 | Osiris Therapeutics, Inc. | Methods of manufacture of immunocompatible amniotic membrane products |
| PL2556145T3 (pl) | 2010-04-07 | 2017-02-28 | Anthrogenesis Corporation | Angiogeneza z zastosowaniem łożyskowych komórek macierzystych |
| KR20130092394A (ko) | 2010-04-08 | 2013-08-20 | 안트로제네시스 코포레이션 | 태반 줄기 세포를 사용한 사르코이드증의 치료 |
| MX342995B (es) | 2010-07-13 | 2016-10-21 | Anthrogenesis Corp | Métodos de generar células asesinas naturales. |
| KR101251217B1 (ko) * | 2010-11-16 | 2013-04-08 | 주식회사 휴림바이오셀 | 중간엽 줄기세포의 내배엽성 세포로의 교차분화 방법 |
| AR084754A1 (es) * | 2010-12-30 | 2013-06-05 | Anthrogenesis Corp | Composiciones que comprenden celulas madre de placenta y plasma rico en plaquetas, y sus metodos de uso |
| US8969315B2 (en) | 2010-12-31 | 2015-03-03 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory RNA molecules |
| DK2714059T3 (en) | 2011-06-01 | 2019-01-21 | Celularity Inc | TREATMENT OF PAIN WHEN USING PLACENT STAM CELLS |
| US10022083B2 (en) | 2011-06-02 | 2018-07-17 | Abdulmohsen E. A. H. Al-Terki | Multiple oral and nasal surgical procedures method and kit |
| US8387798B1 (en) | 2012-04-27 | 2013-03-05 | Abdulmohsen E. A. H. Al-Terki | Mutiple oral and nasal surgical procedures method and kit |
| WO2013025189A1 (en) * | 2011-08-12 | 2013-02-21 | Cryo-Cell International, Inc. | Methods for co-culturing cord blood cells or cord tissue cells with menstrual multipotent cells |
| WO2013055476A1 (en) | 2011-09-09 | 2013-04-18 | Anthrogenesis Corporation | Treatment of amyotrophic lateral sclerosis using placental stem cells |
| TWI419971B (zh) * | 2011-09-28 | 2013-12-21 | Tissue Decomposition, Cell Adhesion and Extraction and Culture of Adult Stem Cells. | |
| US20130136773A1 (en) * | 2011-09-30 | 2013-05-30 | NuTech Spine, Inc. | Expandable Placental Membrane and Methods of Making and Storing Same |
| US9585983B1 (en) | 2011-10-12 | 2017-03-07 | BioDlogics, LLC | Wound covering and method of preparation |
| CN113699105A (zh) * | 2011-12-23 | 2021-11-26 | 人类起源公司 | 包含脱细胞并再群体化的胎盘血管支架的类器官 |
| GB201210147D0 (en) * | 2012-06-08 | 2012-07-25 | Virgin Health Bank Qstp Llc | Method |
| CN102936578B (zh) * | 2012-11-12 | 2014-09-10 | 山东省齐鲁干细胞工程有限公司 | 一种增强间充质干细胞免疫抑制功能的方法 |
| CA2896053A1 (en) | 2012-12-21 | 2014-06-26 | Ocata Therapeutics, Inc. | Methods for production of platelets from pluripotent stem cells and compositions thereof |
| US10905800B1 (en) | 2013-01-29 | 2021-02-02 | BioDlogics, LLC | Ocular covering and method of use |
| EP3622960A1 (en) | 2013-02-05 | 2020-03-18 | Celularity, Inc. | Natural killer cells from placenta |
| US9498327B1 (en) | 2013-03-05 | 2016-11-22 | Biodlogics Llc | Repair of tympanic membrane using human birth tissue material |
| US9789138B1 (en) | 2013-03-06 | 2017-10-17 | BioDlogics, LLC | Neural repair construct and method of use |
| US9770472B1 (en) | 2013-03-08 | 2017-09-26 | Brahm Holdings, Llc | Organ jacket and methods of use |
| US9855301B1 (en) | 2013-03-13 | 2018-01-02 | Biodlogics Llc | Human birth tissue laminate and methods of use |
| SG10201809452RA (en) | 2013-03-15 | 2018-11-29 | Genentech Inc | Cell culture compositions with antioxidants and methods for polypeptide production |
| US9795638B1 (en) | 2013-03-16 | 2017-10-24 | BioDlogics, LLC | Cardiothoracic construct and methods of use |
| CN103142447B (zh) * | 2013-03-18 | 2015-01-14 | 山西医科大学 | 一种表皮干细胞活性成分及含有该活性成分的美容制剂 |
| US9446142B2 (en) * | 2013-05-28 | 2016-09-20 | Mimedx Group, Inc. | Polymer chelator conjugates |
| JP6512759B2 (ja) | 2013-08-19 | 2019-05-15 | 国立研究開発法人国立循環器病研究センター | 羊膜間葉系細胞組成物の製造方法及び凍結保存方法、並びに治療剤 |
| EP3185918B1 (en) | 2014-08-28 | 2021-08-18 | MiMedx Group, Inc. | Collagen reinforced tissue grafts |
| US10265438B1 (en) | 2014-11-03 | 2019-04-23 | BioDlogics, LLC | Methods and compositions for the repair and replacement of connective tissue |
| TW202440903A (zh) | 2015-08-04 | 2024-10-16 | 美商再生元醫藥公司 | 補充牛磺酸之細胞培養基及用法(一) |
| JP6822668B2 (ja) * | 2015-10-28 | 2021-01-27 | 学校法人近畿大学 | 多能性幹細胞の胚様体形成方法および多能性幹細胞の胚様体形成用組成物 |
| US12551509B2 (en) | 2015-11-18 | 2026-02-17 | Lucina Patent Holdco, Llc | Acellular regenerative products and methods of their manufacture |
| ES2982395T3 (es) | 2015-12-23 | 2024-10-15 | Lifenet Health | Membrana placentaria descelularizada y procedimientos de preparación y uso de la misma |
| JP2021518113A (ja) | 2018-03-16 | 2021-08-02 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 心筋細胞を生成及び増殖させるためのwntアゴニスト、並びに生理活性脂質を用いた試薬及び方法 |
| WO2021005531A1 (en) * | 2019-07-08 | 2021-01-14 | Association For The Advancement Of Tissue Engineering And Cell Based Technologies & Therapies (A4Tec) - Associação | Decellularized human chorion membrane as a new substrate to mimic biological barriers, method, kit and uses thereof |
| US12297451B1 (en) | 2019-10-25 | 2025-05-13 | Regeneron Pharmaceuticals, Inc. | Cell culture medium |
| AU2021222052A1 (en) * | 2020-02-21 | 2022-09-01 | Convatec, Inc. | Porcine scaffolds and methods of preparation |
| CN111235101B (zh) * | 2020-03-26 | 2021-11-09 | 海南南医安启生物医疗科技有限公司 | 一种人脐带间充质干细胞培养基及人脐带间充质干细胞的培养方法 |
| CN116018401A (zh) * | 2020-07-29 | 2023-04-25 | 加利福尼亚大学董事会 | 驱动生肌性干细胞扩增的化学物混合物 |
| CN111671972B (zh) * | 2020-07-30 | 2021-10-29 | 中国人民解放军空军军医大学 | 复合外泌体Nidogen-1的组织工程支架及其制备方法 |
| CN114410579B (zh) * | 2022-03-21 | 2023-04-28 | 生物岛实验室 | 组合物、包含其的间充质干细胞无血清培养基及其制备和应用 |
| CN117987350B (zh) * | 2024-04-03 | 2024-06-21 | 优智嘉(天津)生物科技有限公司 | 一种人胎盘绒毛外泌体快速提取试剂盒、提取方法、胎盘外泌体及应用 |
Family Cites Families (82)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4458678A (en) * | 1981-10-26 | 1984-07-10 | Massachusetts Institute Of Technology | Cell-seeding procedures involving fibrous lattices |
| US4520821A (en) * | 1982-04-30 | 1985-06-04 | The Regents Of The University Of California | Growing of long-term biological tissue correction structures in vivo |
| US5192553A (en) * | 1987-11-12 | 1993-03-09 | Biocyte Corporation | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use |
| US5635386A (en) * | 1989-06-15 | 1997-06-03 | The Regents Of The University Of Michigan | Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture |
| US5437994A (en) * | 1989-06-15 | 1995-08-01 | Regents Of The University Of Michigan | Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
| US5464764A (en) * | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
| US5733542A (en) * | 1990-11-16 | 1998-03-31 | Haynesworth; Stephen E. | Enhancing bone marrow engraftment using MSCS |
| US6010696A (en) * | 1990-11-16 | 2000-01-04 | Osiris Therapeutics, Inc. | Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells |
| US5197985A (en) * | 1990-11-16 | 1993-03-30 | Caplan Arnold I | Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells |
| US5226914A (en) * | 1990-11-16 | 1993-07-13 | Caplan Arnold I | Method for treating connective tissue disorders |
| US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US5192312A (en) * | 1991-03-05 | 1993-03-09 | Colorado State University Research Foundation | Treated tissue for implantation and methods of treatment and use |
| US5190556A (en) * | 1991-03-19 | 1993-03-02 | O.B. Tech, Inc. | Cord cutter sampler |
| US5591625A (en) * | 1993-11-24 | 1997-01-07 | Case Western Reserve University | Transduced mesenchymal stem cells |
| US5942496A (en) * | 1994-02-18 | 1999-08-24 | The Regent Of The University Of Michigan | Methods and compositions for multiple gene transfer into bone cells |
| ATE265191T1 (de) * | 1994-03-14 | 2004-05-15 | Cryolife Inc | Herstellungsverfahren von gewebe zur implantation |
| ES2206509T3 (es) * | 1994-06-06 | 2004-05-16 | Case Western Reserve University | Biomatriz para la regeneracion de tejidos. |
| US6174333B1 (en) * | 1994-06-06 | 2001-01-16 | Osiris Therapeutics, Inc. | Biomatrix for soft tissue regeneration using mesenchymal stem cells |
| US5736396A (en) * | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
| US5925567A (en) * | 1995-05-19 | 1999-07-20 | T. Breeders, Inc. | Selective expansion of target cell populations |
| CA2237890C (en) * | 1995-11-16 | 2011-03-29 | Case Western Reserve University | In vitro chondrogenic induction of human mesenchymal stem cells |
| EP0861894B1 (en) * | 1995-11-17 | 2006-03-08 | Asahi Kasei Kabushiki Kaisha | Differentiation-suppressive polypeptide |
| DE69739540D1 (de) * | 1996-04-19 | 2009-10-01 | Osiris Therapeutics Inc | Die wiederherstellung und verstärkung von knochen mittels mesenchymalen stammzellen |
| WO1997045532A1 (en) * | 1996-05-28 | 1997-12-04 | Brown University Research Foundation | Hyaluronan based biodegradable scaffolds for tissue repair |
| US5827740A (en) * | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
| US5919702A (en) * | 1996-10-23 | 1999-07-06 | Advanced Tissue Science, Inc. | Production of cartilage tissue using cells isolated from Wharton's jelly |
| US6152142A (en) * | 1997-02-28 | 2000-11-28 | Tseng; Scheffer C. G. | Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries |
| CA2294944A1 (en) * | 1997-07-03 | 1999-01-14 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells from peripheral blood |
| US7514074B2 (en) * | 1997-07-14 | 2009-04-07 | Osiris Therapeutics, Inc. | Cardiac muscle regeneration using mesenchymal stem cells |
| WO1999003973A1 (en) * | 1997-07-14 | 1999-01-28 | Osiris Therapeutics, Inc. | Cardiac muscle regeneration using mesenchymal stem cells |
| WO1999011287A1 (en) * | 1997-09-04 | 1999-03-11 | Osiris Therapeutics, Inc. | Ligands that modulate differentiation of mesenchymal stem cells |
| DE69922933T2 (de) * | 1998-03-13 | 2005-12-29 | Osiris Therapeutics, Inc. | Anwendungen für humane nicht autologe, mesenchymale stammzellen |
| US6368636B1 (en) * | 1998-03-18 | 2002-04-09 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| WO1999061588A1 (en) * | 1998-05-22 | 1999-12-02 | Osiris Therapeutics, Inc. | Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells |
| WO1999061587A1 (en) * | 1998-05-29 | 1999-12-02 | Osiris Therapeutics, Inc. | Human cd45+ and/or fibroblast + mesenchymal stem cells |
| US6030836A (en) * | 1998-06-08 | 2000-02-29 | Osiris Therapeutics, Inc. | Vitro maintenance of hematopoietic stem cells |
| ES2296413T3 (es) * | 1998-06-08 | 2008-04-16 | Osiris Therapeutics, Inc. | Regulacion de la diferenciacion de celulas madre hematopoyeticas por el uso de celulas madre mesenquimaticas humanas. |
| US6734018B2 (en) * | 1999-06-07 | 2004-05-11 | Lifenet | Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced |
| DE69813908T2 (de) * | 1998-07-28 | 2004-02-05 | Synthes Ag Chur, Chur | Verwendung von kreatinsubstanzen zur behandlung von knochen- und knorpelzellen und geweben |
| WO2000017326A1 (en) * | 1998-09-21 | 2000-03-30 | Musc Foundation For Research Development | Non-hematopoietic cells, including cardiomyocytes and skeletal muscle cells, derived from hematopoietic stem cells and methods of making and using them |
| US6548299B1 (en) * | 1999-11-12 | 2003-04-15 | Mark J. Pykett | Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
| US8075881B2 (en) * | 1999-08-05 | 2011-12-13 | Regents Of The University Of Minnesota | Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure |
| US7015037B1 (en) * | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
| US6239157B1 (en) * | 1999-09-10 | 2001-05-29 | Osiris Therapeutics, Inc. | Inhibition of osteoclastogenesis |
| US6685936B2 (en) * | 1999-10-12 | 2004-02-03 | Osiris Therapeutics, Inc. | Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation |
| AU1778001A (en) * | 1999-11-17 | 2001-05-30 | University Of Rochester | Human ex vivo immune system |
| US6432712B1 (en) * | 1999-11-22 | 2002-08-13 | Bioscience Consultants, Llc | Transplantable recellularized and reendothelialized vascular tissue graft |
| US6428802B1 (en) * | 1999-12-29 | 2002-08-06 | Children's Medical Center Corp. | Preparing artificial organs by forming polylayers of different cell populations on a substrate |
| US6376244B1 (en) * | 1999-12-29 | 2002-04-23 | Children's Medical Center Corporation | Methods and compositions for organ decellularization |
| US6866686B2 (en) * | 2000-01-28 | 2005-03-15 | Cryolife, Inc. | Tissue graft |
| AU2002251935B2 (en) * | 2001-02-14 | 2007-11-29 | Celularity Inc. | Post-partum mammalian placenta, its use and placental stem cells therefrom |
| CA2438501C (en) * | 2001-02-14 | 2014-09-16 | Leo T. Furcht | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| US7347876B2 (en) * | 2001-04-25 | 2008-03-25 | Ray Jui-Fang Tsai | Method for expansion of epithelial stem cells |
| CA2396536A1 (en) * | 2001-08-10 | 2003-02-10 | Saiko Uchida | Human stem cells originated from human amniotic mesenchymal cell layer |
| US8021876B2 (en) * | 2001-11-15 | 2011-09-20 | Children's Medical Center Corporation | Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| US7736892B2 (en) * | 2002-02-25 | 2010-06-15 | Kansas State University Research Foundation | Cultures, products and methods using umbilical cord matrix cells |
| US20030161818A1 (en) * | 2002-02-25 | 2003-08-28 | Kansas State University Research Foundation | Cultures, products and methods using stem cells |
| US20030187515A1 (en) * | 2002-03-26 | 2003-10-02 | Hariri Robert J. | Collagen biofabric and methods of preparing and using the collagen biofabric |
| CN1658848A (zh) * | 2002-04-12 | 2005-08-24 | 细胞基因公司 | 血管生成调节剂的鉴定方法,由此发现的化合物和使用该化合物的治疗方法 |
| CA2481385A1 (en) * | 2002-04-12 | 2003-10-23 | Celgene Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| CA2483010A1 (en) * | 2002-04-19 | 2003-10-30 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Placental derived stem cells and uses thereof |
| US20040161419A1 (en) * | 2002-04-19 | 2004-08-19 | Strom Stephen C. | Placental stem cells and uses thereof |
| BR0311362A (pt) * | 2002-05-28 | 2006-10-31 | Novocell Inc | métodos, composições e fatores de crescimento e de diferenciação para produzir células produtoras de insulina |
| MXPA04011851A (es) * | 2002-05-30 | 2005-03-31 | Celgene Corp | Metodos para utilizar inhibidores de jnk o mkk para modular diferenciacion de celula y para tratar desordenes mieloproliferativos y sindromes mielodispl??sticos. |
| US7422736B2 (en) * | 2002-07-26 | 2008-09-09 | Food Industry Research And Development Institute | Somatic pluripotent cells |
| AU2003298775B2 (en) * | 2002-11-26 | 2008-07-17 | Anthrogenesis Corporation | Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
| JP4790592B2 (ja) * | 2003-02-11 | 2011-10-12 | ダビース,ジヨン・イー | ヒト臍帯のウォートンジェリーからの前駆細胞 |
| US7727550B2 (en) * | 2003-02-21 | 2010-06-01 | The Uab Research Foundation | Biologically active native biomatrix composition |
| ES2569780T3 (es) * | 2003-06-27 | 2016-05-12 | DePuy Synthes Products, Inc. | Células posparto derivadas de tejido placentario y métodos de preparación y uso de las mismas |
| US7569385B2 (en) * | 2003-08-14 | 2009-08-04 | The Regents Of The University Of California | Multipotent amniotic fetal stem cells |
| US20050089513A1 (en) * | 2003-10-28 | 2005-04-28 | Norio Sakuragawa | Side population cells originated from human amnion and their uses |
| BRPI0417186A (pt) * | 2003-12-02 | 2007-03-06 | Celgene Corp | método de tratamento de um indivìduo tendo uma hemoglobinopatia ou uma anemia, de modulação da diferenciação de uma célula-tronco ou precursora de cd34+ para uma linhagem de eritróides, e, composição farmacêutica |
| TWI338714B (en) * | 2003-12-02 | 2011-03-11 | Cathay General Hospital | Method of isolation and enrichment of mesenchymal stem cells from amniotic fluid |
| US20050176139A1 (en) * | 2004-01-12 | 2005-08-11 | Yao-Chang Chen | Placental stem cell and methods thereof |
| CA2559585A1 (en) * | 2004-03-11 | 2005-09-22 | Arblast Co., Ltd. | Biological tissue sheet, method of forming the same and transplantation method by using the sheet |
| NZ553695A (en) * | 2004-08-16 | 2009-10-30 | Cellres Corp Pte Ltd | Isolation of stem/progenitor cells from amniotic membrane of umbilical cord |
| WO2006083394A2 (en) * | 2004-12-21 | 2006-08-10 | Ethicon, Inc. | Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same |
| ZA200800144B (en) * | 2005-06-10 | 2010-02-24 | Celgene Corp | Human placental collagen compositions, processes for their preparation, methods of their use and kits comprising the compositions |
| AU2006265601A1 (en) * | 2005-06-30 | 2007-01-11 | Anthrogenesis Corporation | Repair of tympanic membrane using placenta derived collagen biofabric |
| US20070021762A1 (en) * | 2005-07-13 | 2007-01-25 | Qing Liu | Ocular plug formed from placenta derived collagen biofabric |
| WO2007009062A2 (en) * | 2005-07-13 | 2007-01-18 | Anthrogenesis Corporation | Treatment of leg ulcers using placenta derived collagen biofabric |
| AU2006304274B2 (en) * | 2005-10-13 | 2012-08-16 | Celularity Inc. | Production of oligodendrocytes from placenta-derived stem cells |
-
2007
- 2007-06-08 CA CA002654716A patent/CA2654716A1/en not_active Abandoned
- 2007-06-08 KR KR1020097000342A patent/KR20090031895A/ko not_active Withdrawn
- 2007-06-08 AU AU2007258514A patent/AU2007258514A1/en not_active Abandoned
- 2007-06-08 JP JP2009514393A patent/JP2009539378A/ja active Pending
- 2007-06-08 US US11/811,447 patent/US20080044848A1/en not_active Abandoned
- 2007-06-08 WO PCT/US2007/013507 patent/WO2007146123A2/en not_active Ceased
- 2007-06-08 MX MX2008015645A patent/MX2008015645A/es not_active Application Discontinuation
- 2007-06-08 CN CNA2007800290159A patent/CN101501185A/zh active Pending
- 2007-06-08 EP EP07809398A patent/EP2035552A2/en not_active Withdrawn
- 2007-06-08 ZA ZA200810412A patent/ZA200810412B/xx unknown
-
2008
- 2008-12-09 IL IL195826A patent/IL195826A0/en unknown
-
2017
- 2017-09-27 US US15/717,037 patent/US20180237744A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Han et al. | Optimization of human umbilical cord mesenchymal stem cell isolation and culture methods | |
| David et al. | Co-culture approaches for cultivated meat production | |
| Zhou et al. | Strategies to retain properties of bone marrow–derived mesenchymal stem cells ex vivo | |
| Baksh et al. | Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy | |
| Fehrer et al. | Mesenchymal stem cell aging | |
| Meyerrose et al. | Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors | |
| JP5227318B2 (ja) | 細胞増殖培地 | |
| JP6662777B2 (ja) | 人工心筋(ehm)を産生するための方法 | |
| US10358629B2 (en) | Regulating stem cells | |
| Sommar et al. | Engineering three-dimensional cartilage-and bone-like tissues using human dermal fibroblasts and macroporous gelatine microcarriers | |
| CN102186969A (zh) | 由人多能干细胞制备人皮肤替代品的方法 | |
| WO2006006692A1 (ja) | 低血清培養で選択的に増殖する動物組織遍在性の分化多能性細胞 | |
| Harkness et al. | Selective isolation and differentiation of a stromal population of human embryonic stem cells with osteogenic potential | |
| CN108060126B (zh) | 一种诱导分化的细胞制备间充质干细胞的方法及调控靶点的组合 | |
| Dai et al. | The Human Skin‐Derived Precursors for Regenerative Medicine: Current State, Challenges, and Perspectives | |
| US20210054343A1 (en) | Endocardium-derived adult stem cells and method for producing same | |
| KR101753557B1 (ko) | 줄기세포 증식 향상 배지 조성물 및 줄기세포의 배양방법 | |
| WO2009080794A1 (en) | Method for preparing cell-specific extracellular matrices | |
| US20150329826A1 (en) | Materials and methods for cell culture | |
| Kokai et al. | Scientific principles of adipose stem cells | |
| da Mata Martins et al. | Induction of corneal epithelial differentiation of induced pluripotent and orbital fat-derived stem cells seeded on decellularized human corneas | |
| CN102449139A (zh) | 对多能性干细胞和心肌细胞以外的分化细胞诱导细胞死亡的方法 | |
| US20080317719A1 (en) | Regulating stem cells | |
| CN113166722A (zh) | 羊水细胞来源的细胞外基质及其用途 | |
| KR20210057890A (ko) | 줄기세포 유래 간오가노이드의 제작 및 제1형 혈우병 세포치료제로서의 용도 |